Bitrobius Genetics
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Alderley Park Congleton Rd, Alderley Par...Website
www.bitrobius.comRevenue
<$5 MillionIndustry
About Bitrobius Genetics
Is Bitrobius Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Bitrobius Genetics recently announced quarterly report
Click to see if Bitrobius Genetics had a recent Job posting/layoffs
Check if Bitrobius Genetics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Bitrobius Genetics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Bitrobius Genetics
Product Launch: Get notified when Bitrobius Genetics launches new products
Funding: Get notified immidiatlly once Bitrobius Genetics has new funding data
Bitrobius Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Bitrobius Genetics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Bitrobius Genetics
Compare insights from companies similar to Bitrobius Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Bitrobius Genetics
Bitrobius Genetics Tech Stack
A closer look at the technologies used by Bitrobius Genetics
Top Business Services Companies
Frequently Asked Questions Regarding Bitrobius Genetics
Bitrobius Genetics is pioneering the development of Gentrafix, a revolutionary technology designed to deliver DNA to every affected cell, offering potential cures for genetic diseases. This innovative approach utilizes plasmids that replicate and spread to adjacent cells, addressing the limitations of current gene therapies. The company aims to pro... Read More